Custos de transação e capacitações: influência nas estruturas de governança no setor farmacêutico do Brasil

dc.contributor.advisorBataglia, Walterpt_BR
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/1501003319291177por
dc.contributor.authorNogueira, Antonio Carlos Limapt_BR
dc.creator.Latteshttp://lattes.cnpq.br/6466664720586158por
dc.date.accessioned2016-03-15T19:30:54Z
dc.date.accessioned2020-05-28T18:02:43Z
dc.date.available2013-10-08pt_BR
dc.date.available2020-05-28T18:02:43Z
dc.date.issued2012-08-30pt_BR
dc.description.abstractThe study aimed to analyze the influence of transaction costs and capabilities on vertical integration for the manufacturing step in the pharmaceutical sector in Brazil. This objective resulted from the potential contribution to the ongoing research agenda on the relationship between the approaches of transaction costs and capabilities. The universe of research is the total number of drugs registered at the National Agency of Sanitary Surveillance (ANVISA), which is the federal regulator or drugs in Brazil. The population is the subset of drugs available in the public database Bulário Eletrônico and the levels of analysis are the constructs of vertical integration, experience, diversification, asset specificity and bargaining power. The unit of analysis is the transaction of drug manufacturing and the object of analysis is the registry of the drug. I developed and proposed a structural model composed of a set of hypotheses with causal relationships between constructs. The model includes first order latent variables and measurable indicators based on data available on database and in the websites of the companies. With these definitions, I collected the data for each drug, including pharmaceutical form, therapeutic class, regulatory category and vertical integration of the manufacturing transaction. To test the hypotheses I conducted a confirmatory factor analysis of the measurement model through a structural equation model solved by Partial Least Squares. The first theoretical implication of the results is the identification of significant relationships between constructs related to transaction costs (asset specificity and bargaining power) and capabilities (experience and diversification) as well as relations between vertical integration and the other constructs. The second implication is the positive relationship between diversification and vertical integration. As diversification is an indicator of capabilities, the result implies that the limits of the firm reflect a bundle of capabilities expressed by processes and routines. The result could be subject to criticism that the vertical integration adoption may be resultant of cost considerations and delimitation of the scope based on the stages of greatest value to the company. The third implication is the existence of a negative relationship between asset specificity and vertical integration. The result seems to indicate the low strategic value of the manufacturing transaction in the value chain in the pharmaceutical industry. It seems that companies tend to outsource manufacturing transaction precisely for products with specific attributes. The fourth implication is the lack of influence of bargaining power on vertical integration. This result may be due to two aspects: the first is the very structure of the market portrayed by population and second is the low importance of transaction registration to generate value. In this population, the market is competitive for the more widespread forms and classes and more concentrated for products with rarer forms and classes. On the other hand, the low relevance of the transaction as a strategic activity can make decisions on vertical integration does not take into account the bargaining power of the company.eng
dc.description.sponsorshipFundo Mackenzie de Pesquisapt_BR
dc.formatapplication/pdfpor
dc.identifier.urihttp://dspace.mackenzie.br/handle/10899/23201
dc.languageporpor
dc.publisherUniversidade Presbiteriana Mackenziepor
dc.rightsAcesso Abertopor
dc.subjectcoordenação verticalpor
dc.subjectterceirizaçãopor
dc.subjectcadeia de suprimentospor
dc.subjectintegração verticalpor
dc.subjectfabricação de medicamentospor
dc.subjecttransaction costseng
dc.subjectpharmaceutical industryeng
dc.subjectcapabilitieseng
dc.subjectgovernance structureseng
dc.subject.cnpqCNPQ::CIENCIAS SOCIAIS APLICADAS::ADMINISTRACAO::ADMINISTRACAO DE EMPRESASpor
dc.thumbnail.urlhttp://tede.mackenzie.br/jspui/retrieve/2979/Antonio%20Carlos%20Lima%20Nogueira.pdf.jpg*
dc.titleCustos de transação e capacitações: influência nas estruturas de governança no setor farmacêutico do Brasilpor
dc.typeTesepor
local.contributor.board1Silva, Adilson Aderito dapt_BR
local.contributor.board1Latteshttp://lattes.cnpq.br/3999075737061835por
local.contributor.board2Zylbersztajn, Deciopt_BR
local.contributor.board2Latteshttp://lattes.cnpq.br/0985763814519824por
local.contributor.board3Azevedo, Paulo Furquim dept_BR
local.contributor.board3Latteshttp://lattes.cnpq.br/7286319140069530por
local.contributor.board4Brito, Eliane Pereira Zamithpt_BR
local.contributor.board4Latteshttp://lattes.cnpq.br/6991824880537204por
local.publisher.countryBRpor
local.publisher.departmentAdministraçãopor
local.publisher.initialsUPMpor
local.publisher.programAdministração de Empresaspor
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Antonio Carlos Lima Nogueira.pdf
Tamanho:
993.16 KB
Formato:
Adobe Portable Document Format
Descrição: